- Investing Ideas
- /
- U.S. Top High Growth Tech & AI Stocks - Spotless Financials
U.S. Top High Growth Tech & AI Stocks - Spotless Financials
Results
73
Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.
73 companies
Palantir Technologies
Market Cap: US$386.7b
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
PLTR
US$163.55
7D
-2.3%
1Y
148.8%
Procore Technologies
Market Cap: US$11.2b
Provides a cloud-based construction management platform and related products and services in the United States and internationally.
PCOR
US$73.81
7D
1.0%
1Y
-8.0%
RenovoRx
Market Cap: US$28.8m
A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$0.87
7D
10.6%
1Y
-36.4%
Pelthos Therapeutics
Market Cap: US$83.0m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$27.11
7D
-9.7%
1Y
333.6%
Zscaler
Market Cap: US$44.4b
Operates as a cloud security company worldwide.
ZS
US$289.73
7D
-1.2%
1Y
37.8%
Duos Technologies Group
Market Cap: US$196.2m
Designs, develops, deploys, and operates intelligent technology solutions in North America.
DUOT
US$9.61
7D
8.7%
1Y
78.0%
Circle Internet Group
Market Cap: US$17.1b
Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.
CRCL
US$70.11
7D
-8.5%
1Y
n/a
Workday
Market Cap: US$60.5b
Provides enterprise cloud applications in the United States and internationally.
WDAY
US$233.69
7D
3.6%
1Y
-13.5%
ADMA Biologics
Market Cap: US$4.4b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$19.21
7D
22.4%
1Y
-12.0%
Viridian Therapeutics
Market Cap: US$3.1b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$31.41
7D
9.9%
1Y
43.4%
Sanmina
Market Cap: US$8.4b
Provides integrated manufacturing solutions, components, products and repair, logistics, and after-market services in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.
SANM
US$154.32
7D
-1.4%
1Y
97.0%
Kiniksa Pharmaceuticals International
Market Cap: US$3.2b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$42.71
7D
1.3%
1Y
91.4%
Atlassian
Market Cap: US$39.2b
Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.
TEAM
US$149.04
7D
1.7%
1Y
-43.2%
HubSpot
Market Cap: US$18.7b
Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.
HUBS
US$371.51
7D
0.9%
1Y
-49.1%
Precigen
Market Cap: US$1.4b
A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$3.67
7D
-24.3%
1Y
326.8%
Zeta Global Holdings
Market Cap: US$4.3b
Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.
ZETA
US$18.03
7D
6.8%
1Y
-10.7%
Market Cap: US$37.0b
Operates a digital community in the United States and internationally.
RDDT
US$218.48
7D
17.7%
1Y
61.1%
Invivyd
Market Cap: US$529.2m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$2.27
7D
-9.2%
1Y
236.7%
BioRestorative Therapies
Market Cap: US$9.3m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.11
7D
-10.5%
1Y
-26.0%
Interlink Electronics
Market Cap: US$64.8m
Provides sensors and printed electronics for use in human-machine interface (HMI) devices and internet-of-things solutions in the United States, Asia, the Middle East, Europe, and internationally.
LINK
US$4.23
7D
6.8%
1Y
52.9%
Krystal Biotech
Market Cap: US$6.2b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$216.97
7D
6.0%
1Y
10.4%
SELLAS Life Sciences Group
Market Cap: US$220.8m
A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.
SLS
US$1.44
7D
-9.4%
1Y
20.0%
Cheetah Mobile
Market Cap: US$239.2m
Provides internet services, artificial intelligence (AI), and other services in the People’s Republic of China, Hong Kong, Japan, and internationally.
CMCM
US$8.51
7D
33.6%
1Y
64.3%
Semrush Holdings
Market Cap: US$1.8b
Develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally.
SEMR
US$11.81
7D
0.4%
1Y
-12.0%
Roivant Sciences
Market Cap: US$14.5b
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
ROIV
US$20.86
7D
2.6%
1Y
64.4%
Savara
Market Cap: US$1.3b
A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.
SVRA
US$5.15
7D
23.5%
1Y
48.8%
Gyre Therapeutics
Market Cap: US$715.3m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$7.72
7D
0.7%
1Y
-36.1%
MNTN
Market Cap: US$997.3m
Operates a technology platform that brings performance marketing to Connected TV.
MNTN
US$13.57
7D
-3.1%
1Y
n/a
Trade Desk
Market Cap: US$18.9b
Operates as a technology company in the United States and internationally.
TTD
US$39.09
7D
-3.4%
1Y
-69.7%
Applied Optoelectronics
Market Cap: US$1.5b
Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.
AAOI
US$22.73
7D
8.8%
1Y
-38.6%
Annexon
Market Cap: US$652.7m
A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
ANNX
US$4.44
7D
38.8%
1Y
-16.1%
Aprea Therapeutics
Market Cap: US$7.4m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.21
7D
1.7%
1Y
-59.3%
Protagonist Therapeutics
Market Cap: US$5.6b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$89.86
7D
5.6%
1Y
99.9%
Arcturus Therapeutics Holdings
Market Cap: US$179.9m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$6.80
7D
2.7%
1Y
-59.8%
Pure Storage
Market Cap: US$27.0b
Provides data storage and management technologies, products, and services in the United States and internationally.
PSTG
US$83.15
7D
1.2%
1Y
52.3%
CarGurus
Market Cap: US$3.4b
Operates an online automotive platform for buying and selling vehicles in the United States and internationally.
CARG
US$36.02
7D
3.0%
1Y
-1.2%